INJECT ApS: Financial statements 2024
CVR: 33867581
Source: annual report 2024, Danish Business Authority
01/09/2023 – 31/08/2024
INJECT ApS (CVR 33867581) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2024 report amounted to DKK 0.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 0
- Total Assets
- DKK 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 0 | 0 | 0 | - |
| 2023 | - | 0 | 0 | 0 | - |
| 2022 | - | 0 | 0 | 0 | - |
| 2021 | 0 | 0 | 0 | 0 | - |
| 2020 | 0 | 0 | 0 | 0 | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
INJECT ApS has published its annual report for 2023. Gross profit came to DKK 0, and the net result was DKK 0.
As of February 19, 2024, Felix Hetting is registered as director of INJECT ApS.
As of February 19, 2024, Mikael Hans Andranik Hetting has stepped down as director of INJECT ApS.
About INJECT ApS
INJECT ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2011. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Felix Hetting. The company is owned by MAFO ApS, Tina Hetting Holding I ApS and ASYRINGE LIMITED. According to the 2019 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 0.